SCHEMBL10160157

SCHEMBL10160157

CC(C)(C)OC(=O)Nc1cccc(CNC(=O)c2ccccc2)c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SENP1 Q9P0U3 9/20 0.55
NR1H4 Q96RI1 1/20 0.54
SENP2 Q9HC62 4/20 0.53
SENP5 Q96HI0 3/20 0.53
PRMT5 O14744 1/20 0.53
WDR77 Q9BQA1 1/20 0.53
LMNA P02545 2/20 0.51
RAB9A P51151 1/20 0.51
MAPK1 P28482 1/20 0.51
AURKA O14965 1/20 0.51
RPS6KB1 P23443 1/20 0.51
ALDH1A1 P00352 1/20 0.49
HPGD P15428 1/20 0.49
HTT P42858 1/20 0.49
NAMPT P43490 1/20 0.49
MAPT P10636 1/20 0.49
HDAC1 Q13547 1/20 0.48
PPARG P37231 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13623005 0.89 SENP1 (0.52) SENP1NR1H4SENP2SENP5PRMT5
SCHEMBL10160107 0.86 MAPT (0.53) RAB9AAURKARPS6KB1HPGDHTT
SCHEMBL6679114 0.85 SENP1 (0.48) SENP1NR1H4SENP2SENP5LMNA
SCHEMBL13623004 0.85 SENP5 (0.54) SENP1SENP2SENP5LMNAALDH1A1
SCHEMBL30270551 0.85 AURKA (0.57) SENP1AURKARPS6KB1
SCHEMBL31710947 0.85 AURKA (0.54) SENP1SENP2SENP5PRMT5WDR77
SCHEMBL16527267 0.85 AURKA (0.54) SENP1SENP2SENP5PRMT5WDR77
SCHEMBL306845 0.84 ROCK2 (0.60) SENP1NR1H4SENP2SENP5LMNA
SCHEMBL13923460 0.84 PPARG (0.49) SENP1NR1H4PRMT5WDR77LMNA
SCHEMBL13853708 0.82 AURKA (0.53) LMNARAB9AAURKARPS6KB1NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093266-B2 Rho kinase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-01-10 US disclosed
US-20100041645-A1 RHO KINASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041645-A1 RHO KINASE INHIBITORS CIT, ROCK1, RHOT2 SENP1 2233/4885NR1H4 2683/4885SENP2 2826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.